SCHEMBL6329414

SCHEMBL6329414

COc1ccc(C(=O)CO)cc1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 7/20 0.53
TAS1R1 Q7RTX1 7/20 0.53
PDE4D Q08499 1/20 0.51
KMT2A Q03164 3/20 0.50
ALDH1A1 P00352 3/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 3/20 0.49
POLB P06746 1/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MEN1 O00255 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
HTT P42858 1/20 0.48
KCNH2 Q12809 1/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
ALOX15 P16050 1/20 0.48
CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12780432 0.86 MEN1 (0.59) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL6136939 0.86 TAS1R3 (0.53) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL2166529 0.85 GSK3B (0.54) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL9155650 0.85 PDE4D (0.54) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL29620782 0.85 GSK3B (0.54) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL22570710 0.85 TAS1R3 (0.51) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL3893527 0.84 TSHR (0.66) PDE4DKMT2AALDH1A1MAPTPOLB
Hydrochloric Acid SCHEMBL29393777 0.83 TAS1R3 (0.50) TAS1R3TAS1R1PDE4DKMT2AALDH1A1
SCHEMBL3950960 0.83 TAS1R3 (0.57) TAS1R3TAS1R1PDE4DALDH1A1MAPT
SCHEMBL23782335 0.82 TAS1R3 (0.56) TAS1R3TAS1R1PDE4DMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABOTT LABORATORIES 2005-09-22 US disclosed
US-20050187387-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209274-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R TAS1R3 90/4885TAS1R1 74/4885PDE4D 1827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.